drug protocol number

RC14-055-R

drug sponsor

KAIMRC

drug study

PEGINTERFERON ALFA-2A/ RIBAVIRIN/ R0209963

drug trial site

King Abdulaziz Medical City NG (Riyadh)

drug status

Ongoing

drug phase